The power and potential of BIOMAP to elucidate host-microbiome interplay in skin inflammatory diseases
Autor: | Elke Rodriguez, Nanna Fyhrquist, Ellen H. van den Bogaard, Matthias Reiger, Paul J. Bryce, Conor Broderick, Hanna Sinkko, Kilian Eyerich, Mathis Hjort Hjelmsø, Avidan U. Neumann, Frits Koning, Catherine H. Smith, Claudia Traidl-Hoffmann, Harri Alenius, Carsten Flohr, Helen Alexander, Jakob Stokholm, Lucas Moitinho-Silva, Péter Oláh, Bernhard Homey, Dario Greco, Stephan Weidinger, Klaus Bønnelykke |
---|---|
Rok vydání: | 2021 |
Předmět: |
Disease onset
Work package Atopic Dermatitis Biomarkers Microbiome Psoriasis microbiome Dermatology Gut flora Bioinformatics Biochemistry Dermatitis Atopic 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine medicine Humans ddc:610 Molecular Biology 030304 developmental biology Skin 0303 health sciences biology atopic dermatitis business.industry Microbiota biomarkers Atopic dermatitis psoriasis biology.organism_classification medicine.disease 3. Good health Review article Potential biomarkers business Inflammatory diseases Radboud Institute for Molecular Life Sciences [Radboudumc 5] |
Zdroj: | Experimental Dermatology, 30, 10, pp. 1517-1531 Alenius, H, Sinkko, H, Moitinho-Silva, L, Rodriguez, E, Broderick, C, Alexander, H, Reiger, M, Hjelmsø, M H, Fyhrquist, N, Olah, P, Bryce, P, Smith, C, Koning, F, Eyerich, K, Greco, D, van den Bogaard, E H, Neumann, A U, Traidl-Hoffmann, C, Homey, B, Flohr, C, Bønnelykke, K, Stokholm, J & Weidinger, S 2021, ' The power and potential of BIOMAP to elucidate host-microbiome interplay in skin inflammatory diseases ', Experimental Dermatology, vol. 30, no. 10, pp. 1517-1531 . https://doi.org/10.1111/exd.14446 Exp. Dermatol. 30, 1517-1531 (2021) Experimental Dermatology Experimental Dermatology, 30, 1517-1531 |
ISSN: | 0906-6705 1517-1531 |
DOI: | 10.1111/exd.14446 |
Popis: | Contains fulltext : 237768.pdf (Publisher’s version ) (Open Access) The two most common chronic inflammatory skin diseases are atopic dermatitis (AD) and psoriasis. The underpinnings of the remarkable degree of clinical heterogeneity of AD and psoriasis are poorly understood and, as a consequence, disease onset and progression are unpredictable and the optimal type and time point for intervention are as yet unknown. The BIOMAP project is the first IMI (Innovative Medicines Initiative) project dedicated to investigating the causes and mechanisms of AD and psoriasis and to identify potential biomarkers responsible for the variation in disease outcome. The consortium includes 7 large pharmaceutical companies and 25 non-industry partners including academia. Since there is mounting evidence supporting an important role for microbial exposures and our microbiota as factors mediating immune polarization and AD and psoriasis pathogenesis, an entire work package is dedicated to the investigation of skin and gut microbiome linked to AD or psoriasis. The large collaborative BIOMAP project will enable the integration of patient cohorts, data and knowledge in unprecedented proportions. The project has a unique opportunity with a potential to bridge and fill the gaps between current problems and solutions. This review highlights the power and potential of the BIOMAP project in the investigation of microbe-host interplay in AD and psoriasis. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |